Examining the association of FOLH1 with signatures corresponding with AR signaling versus NEPC revealed a positive correlation of FOLH1 with AR signaling scores and a modestly negative correlation with NEPC scores, highlighting the inverse relationship of these two signatures and the need for non-PSMA-targeted approaches for prostate tumors with neuroendocrine features. The gene discussed is AR; the disease is prostate neoplasm.